But here is the uncomfortable truth that nobody talks about openly: not everyone can get it, not everyone can afford it, and not everyone tolerates it well
Semaglutide (Ozempic, Wegovy, Rybelsus) is a prescription GLP-1 medication used for weight loss and weight management, type 2 diabetes treatment, or to reduce the risk of chronic kidney disease and major cardiovascular events in certain patients with type 2 diabetes
The trial involved 636 participants who were randomly assigned to receive tirzepatide (5 mg, 10 mg, or 15 mg) or dulaglutide (0.75 mg) once a week for 52 weeks
When administered under the guidance of our healthcare providers, tirzepatide can help stimulate insulin release, decrease blood sugar levels, and slow stomach emptying
Smith is dedicated to helping you achieve your weight loss goals with the latest advancements in medical treatments
In 2023, the FDA updated the side effects for tirzepatide and semaglutide to emphasize that an ileus, an intestinal blockage, has been reported as a possible side effect
